With consistent advanced care, most uncomplicated diabetic foot ulcers heal in 12–20 weeks. Wounds that fail to reduce in size by 50% in the first 4 weeks are unlikely to close with standard care alone and typically need an advanced therapy such as a skin substitute. Without treatment, diabetic foot ulcers carry a high risk of infection and amputation.
Clinical research consistently shows that a diabetic foot ulcer should reduce its surface area by at least 50% in the first 4 weeks of standard care (offloading, moist wound therapy, infection control, glucose management). Wounds that meet this benchmark usually heal within 12–20 weeks. Wounds that do not meet it should be re-evaluated for vascular compromise, biofilm, osteomyelitis, or the need for an advanced biologic.
Several factors lengthen healing time and should be addressed early.
If the 50% reduction benchmark is not met by week 4, Medicare LCD L35041 supports moving to a cellular and tissue-based product (skin substitute) such as Apligraf, Oasis, GraftJacket, or AmnioBand. Adding these products at the right point in care often achieves closure in patients who would otherwise progress to amputation.
With consistent advanced care, most uncomplicated diabetic foot ulcers heal in 12–20 weeks. Wounds that fail to reduce in size by 50% in the first 4 weeks are unlikely to close with standard care alone and typically need an advanced therapy such as a skin substitute. Without treatment, diabetic foot ulcers carry a high risk of infection and amputation.
Call 877-545-1300 or request a provider to begin care. Healix360 serves Southern California and Nevada and accepts Medicare Part B and most major insurance plans.